Search

everythinglearnresearchcommunity

for

Search:↓

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

More severe hair loss is linked to more sexual dysfunction in both men and women.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Vitamin D levels are not linked to alopecia areata.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Computational techniques can improve drug development for treating certain conditions.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.